Optimization of plasma treatment, manipulative variables and coating composition for the controlled filling and coating of a microstructured reservoir stent

Journal of Medical Devices, Transactions of the ASME

Volumn 3, Issue 1, 2009, Pages

  Mekki, Mustapha ^a   Durual, Stéphane ^c   Scherrer, Susanne S ^c   Lammers, Johannes ^b   Wiskott, H W Anselm ^c  

^a Hexacath   (France)

^b University of Geneva ^*

^c UNIVERSITY OF GENEVA   (Switzerland)

Author keywords

Drug eluting stent; Drug loading; Microstructured surface; Surface energy

Indexed keywords

COATING COMPOSITIONS; COATING SOLUTION; COATING THICKNESS; CORONARY STENTS; DEXAMETHASONES; DRUG LOADING; DRUG-ELUTING STENTS; FILLING SOLUTIONS; L-ARGININE; MICROSTRUCTURED; MICROSTRUCTURED SURFACES; MULTI FREQUENCY; OPTIMIZED PROCESS; PLASMA SURFACES; PLASMA TREATMENT; SURFACE COATINGS; SURFACE ENERGY; THERAPEUTIC AGENTS; ULTRASONIC VIBRATION;

AMINO ACIDS; DATA COMMUNICATION EQUIPMENT; ETHYLENE; FILLING; GLYCOLS; INTERFACIAL ENERGY; MICROCAVITIES; OPTIMIZATION; PLASMA APPLICATIONS; PRESSURE EFFECTS; PROTECTIVE COATINGS; SURFACE CHEMISTRY; THICKNESS MEASUREMENT; WEAR RESISTANCE;

DRUG PRODUCTS;

ARGININE; DEXAMETHASONE; MACROGOL 8000; PROPANOL; TITANIUM DERIVATIVE; WATER;

ARTICLE; CHEMICAL COMPOSITION; CONTROLLED DRUG RELEASE; CORONARY ARTERY; CORONARY STENT; DRUG ELUTING STENT; ELUTION; EQUIPMENT DESIGN; FLOW RATE; GAS; HEART; HIGH FREQUENCY OSCILLATION; MATERIAL COATING; PLASMA; POWER ANALYSIS; PRESSURE; PROCESS OPTIMIZATION; ULTRASOUND; VASCULAR RESISTANCE;

EID: 77956332728     PISSN: 19326181     EISSN: 1932619X     Source Type: Journal    
DOI: 10.1115/1.3081394     Document Type: Article

References (34)

1. American Heart Association, 2008.
2. Lim, I. A. L., 2004, "Biocompatibility of Stent Materials," MIT Undergraduate Research Journal, 11, pp. 33-37.
3. Schatz, R. A., Palmaz, J. C., Tio, F. O., Garcia, F., Garcia, O., and Reuter, S. R., 1987, "Balloon-Expandable Intracoronary Stents in the Adult Dog," Circulation, 76(2), pp. 450-457.
4. Serruys, P. W., de Jaegere, P., Kiemeneij, F., Macaya, C., Rutsch, W., Heyndrickx, G., Emanuelsson, H., Marco, J., Legrand, V., Materne, P., Belardi, J., Sigwart, U., Colombo, A., Goy, J. J., van den Heuvel, P., Delcan, P., and Morele, M.-A., 1994, "A Comparison of Balloon-Expandable-Stent Implantation With Balloon Angioplasty in Patients With Coronary Artery Disease," N. Engl. J. Med., 331(8), pp. 489-495. (Pubitemid 24256751)
5. Fischman, D. L., Leon, M. B., Baim, D. S., Schatz, R. A., Savage, M. P., Penn, I., Detre, K., Veltri, L., Ricci, D., Nobuyoshi, M., Cleman, M., Heuser, R., Almond, D., Teirstein, P. S., Fish, R. D., Colombo, A., Brinker, J., Moses, J., Shaknovich, A., Hirshfeld, J., Bailey, S., Ellis, S., Rake, R., and Goldberg, S., 1994, "A Randomized Comparison of Coronary-Stent Placement and Balloon Angioplasty in the Treatment of Coronary Artery Disease," N. Engl. J. Med., 331(8), pp. 496-501. (Pubitemid 24256752)
6. Kastrati, A., Mehilli, J., Von Beckerath, N., Dibra, A., Hausleiter, J., Pache, J., Schuhlen, H., Schmitt, C., Dirschinger, J., and Schomig, A., 2005, "Sirolimus- Eluting Stent or Paclitaxel-Eluting Stent Vs Balloon Angioplasty for Prevention of Recurrences in Patients With Coronary In-Stent Restenosis: A Randomized Controlled Trial," JAMA, J. Am. Med. Assoc., 293(2), pp. 165-171.
7. Lowe, H. C., Oesterle, S. N., and Khachigian, L. M., 2002, "Coronary in-Stent Restenosis: Current Status and Future Strategies," J. Am. Coll. Cardiol., 39(2), pp. 183-193.
8. Schwartz, R. S., Topol, E. J., Serruys, P. W., Sangiorgi, G., and Holmes, D. R., Jr., 1998, "Artery Size, Neointima, and Remodeling: Time for Some Standards," J. Am. Coll. Cardiol., 32(7), pp. 2087-2094.
9. Riessen, R. and Isner, J. M., 1994, "Prospects for Site-Specific Delivery of Pharmacologic and Molecular Therapies," J. Am. Coll. Cardiol., 23(5), pp. 1234-1244.
10. Poon, M., Marx, S. O., Gallo, R., Badimon, J. J., Taubman, M. B., and Marks, A. R., 1996, "Rapamycin Inhibits Vascular Smooth Muscle Cell Migration," J. Clin. Invest., 98(10), pp. 2277-2283.
11. Suzuki, T., Kopia, G., Hayashi, S., Bailey, L. R., Llanos, G., Wilensky, R., Klugherz, B. D., Papandreou, G., Narayan, P., Leon, M. B., Yeung, A. C., Tio, F., Tsao, P. S., Falotico, R., and Carter, A. J., 2001, "Stent-Based Delivery of Sirolimus Reduces Neointimal Formation in a Porcine Coronary Model," Circulation, 104(10), pp. 1188-1193. (Pubitemid 32830406)
12. Fumoleau, P., Coudert, B., Isambert, N., and Ferrant, E., 2007, "Novel Tubulin-Targeting Agents: Anticancer Activity and Pharmacologic Profile of Epothilones and Related Analogues," Ann. Oncol., 18(5), pp. v9-v15.
13. Palmaz, J. C., 2004, "Intravascular Stents in the Last and the Next 10 Years," J. Endovasc. Ther., 11(2), pp. II200-II206.
14. Watt, J., Wadsworth, R., Kennedy, S., and Oldroyd, K. G., 2008, "Pro-Healing Drug-Eluting Stents: A Role for Antioxidants?," Clin. Sci., 114(4), pp. 265-273.
15. Mintz, G. S., 2007, "Features and Parameters of Drug-Eluting Stent Deployment Discoverable by Intravascular Ultrasound," Am. J. Cardiol., 100(8B), pp. 26M-35M.
16. Khan, R., Agrotis, A., and Bobik, A., 2007, "Understanding the Role of Transforming Growth Factor- β1 in Intimal Thickening After Vascular Injury," Cardiovasc. Res., 74(2), pp. 223-234.
17. Peranzoni, E., Marigo, I., Dolcetti, L., Ugel, S., Sonda, N., Taschin, E., Mantelli, B., Bronte, V., and Zanovello, P., 2008, "Role of Arginine Metabolism in Immunity and Immunopathology," Immunobiology, 212(9-10), pp. 795-812. (Pubitemid 350246262)
18. Huang, Y., Wang, L., Li, S., Liu, X., Lee, K., Verbeken, E., Van De Werf, F., and De Scheerder, I., 2006, "Stent-Based Tempamine Delivery on Neointimal Formation in a Porcine Coronary Model," Acute Cardiac Care, 8(4), pp. 210-216. (Pubitemid 44950062)
19. Anis, R. R. and Karsch, K. R., 2006, "The Future of Drug Eluting Stents," Heart, 92(5), pp. 585-588.
20. Karoussos, I. A., Wieneke, H., Sawitowski, T., Wnendt, S., Fischer, A., Dirsch, O., Dahmen, U., and Erbel, R., 2002, "Inorganic Materials as Drug Delivery Systems in Coronary Artery Stenting," Materialwiss. Werkstofftech., 33, pp. 738-746. (Pubitemid 36201860)
21. Landolt, D., Chauvy, P. F., and Zinger, O., 2003, "Electrochemical Micromachining, Polishing and Surface Structuring of Metals: Fundamental Aspects and New Developments," Electrochim. Acta, 48, pp. 3185-3201.
22. Windecker, S., Simon, R., Lins, M., Klauss, V., Eberli, F. R., Roffi, M., Pedrazzini, G., Moccetti, T., Wenaweser, P., Togni, M., Tuller, D., Zbinden, R., Seiler, C., Mehilli, J., Kastrati, A., Meier, B., and Hess, O. M., 2005, "Randomized Comparison of a Titanium-Nitride-Oxide-Coated Stent With a Stainless Steel Stent for Coronary Revascularization: The TINOX Trial," Circulation, 111(20), pp. 2617-2622.
23. Kirk, S. J., Hurson, M., Regan, M. C., Holt, D. R., Wasserkrug, H. L., and Barbul, A., 1993, "Arginine Stimulates Wound Healing and Immune Function in Elderly Human Beings," Surgery (St. Louis), 114(2), pp. 155-159.
24. Wittmann, F., Prix, N., Mayr, S., Angele, P., Wichmann, M. W., Van Den Engel, N. K., Hernandez-Richter, T., Chaudry, I. H., Jauch, K. W., and Angele, M. K., 2005, "L-Arginine Improves Wound Healing After Trauma- Hemorrhage by Increasing Collagen Synthesis," J. Trauma: Inj., Infect., Crit. Care, 59(1), pp. 162-168. (Pubitemid 41271658)
25. O'Brien, M. E., 2008, "Single-Agent Treatment With Pegylated Liposomal Doxorubicin for Metastatic Breast Cancer," Anti-Cancer Drugs, 19(1), pp. S1-S7.
26. Potter, W., Kalil, R. E., and Kao, W. J., 2008, "Biomimetic Material Systems for Neural Progenitor Cell-Based Therapy," Front. Biosci., 13, pp. 806-821. (Pubitemid 351594730)
27. Rajkumar, S. V. and Palumbo, A., 2007, "Management of Newly Diagnosed Myeloma," Hematol. Oncol. Clin. North Am., 21(6), pp. 1141-1156.
28. Liu, X., Huang, Y., Hanet, C., Vandormael, M., Legrand, V., Dens, J., Vandenbossche, J. L., Missault, L., Vrints, C., and De Scheerder, I., 2003, "Study of Antirestenosis With the Biodivysio Dexamethasone-Eluting Stent (Stride): A First-in-Human Multicenter Pilot Trial," Catheterization and Cardiovascular Interventions, 60(2), pp. 172-178. (Pubitemid 37203992)
29. Johnson, L. L., Schofield, L. M., Weber, D. K., Kolodgie, F., Virmani, R., and Khaw, B. A., 2004, "Uptake of 111in-Z2d3 on Spect Imaging in a Swine Model of Coronary Stent Restenosis Correlated With Cell Proliferation," J. Nucl. Med., 45(2), pp. 294-299. (Pubitemid 47618653)
30. Zhang, J., Rodila, R., Watson, P., Ji, Q., and El-Shourbagy, T. A., 2007, "Determination of Sirolimus in Rabbit Arteries Using Liquid Chromatography Separation and Tandem Mass Spectrometric Detection," Biomed. Chromatogr., 21(10), pp. 1036-1044. (Pubitemid 47495628)
31. Prabhu, S. and Hossainy, S., 2007, "Modeling of Degradation and Drug Release From a Biodegradable Stent Coating," J. Biomed. Mater. Res., 80A(3), pp. 732-741. (Pubitemid 46239086)
32. Janicki, C., Hwang, C. W., and Edelman, E. R., 2003, "Dose Model for Stent- Based Delivery of a Radioactive Compound for the Treatment of Restenosis in Coronary Arteries," Med. Phys., 30(10), pp. 2622-2628. (Pubitemid 37266759)
33. Balakrishnan, B., Tzafriri, A. R., Seifert, P., Groothuis, A., Rogers, C., and Edelman, E. R., 2005, "Strut Position, Blood Flow, and Drug Deposition: Implications for Single and Overlapping Drug-Eluting Stents," Circulation, 111(22), pp. 2958-2965. (Pubitemid 40814189)
34. Mongrain, R., Faik, I., Leask, R. L., Rodes-Cabau, J., Larose, E., and Bertrand, O. F., 2007, "Effects of Diffusion Coefficients and Struts Apposition Using Numerical Simulations for Drug Eluting Coronary Stents," ASME J. Biomech. Eng., 129(5), pp. 733-742. (Pubitemid 350005835)